Larkspur, CA, United States of America

Jennifer O'Hara Lauchle

This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer O'Hara Lauchle. Retrieved from https://idiyas.com/inventor/jennifer-o-hara-lauchle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Breast Cancer Treatment by Jennifer O'Hara Lauchle

Introduction

Jennifer O'Hara Lauchle is a prominent inventor based in Larkspur, California. She has made significant contributions to the field of oncology, particularly in the treatment of breast cancer. Her innovative approach focuses on combination therapies that enhance treatment efficacy.

Latest Patents

Jennifer holds a patent for her groundbreaking work titled "Treatment of breast cancer using combination therapies comprising GDC-9545 and a CDK4/6 inhibitor." This patent outlines the use of combination therapies that include GDC-9545 and a CDK4/6 inhibitor for treating locally advanced or metastatic breast cancer. Her research aims to improve patient outcomes and provide new hope for those affected by this disease.

Career Highlights

Jennifer is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. Her work at Genentech has allowed her to collaborate with some of the brightest minds in the industry, further advancing her research and contributions to cancer treatment.

Collaborations

Some of her notable coworkers include Sandra Milan and Melanie Carol Smitt. Their collaborative efforts have played a crucial role in the development of effective therapies for breast cancer.

Conclusion

Jennifer O'Hara Lauchle's contributions to breast cancer treatment through her innovative patent and work at Genentech highlight her dedication to improving patient care. Her research continues to pave the way for advancements in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…